FXIa-IN-13
FXIa-IN-13 (example 1) is an Factor Xa inhibitor with antithrombotic activity. FXIa-IN-13 inhibits arteriovenous thrombosis in vivo and in vitro[1].
Product Specifications
CAS Number
[2629361-99-3]
UNSPSC
12352005
Target
Factor Xa
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/fxia-in-13.html
Solubility
10 mM in DMSO
Smiles
CC(C(C=C1)=C(C(C(OC)=NN2[C@H](C(NC(C=C3)=CC=C3C(O)=O)=O)CC4=CC=CC=C4)=CC2=O)C=C1Cl)=O
Molecular Formula
C29H24ClN3O6
Molecular Weight
545.97
References & Citations
[1]Xiao Ying, et al. Pharmaceutical use of fxia inhibitor compound or salt thereof. World Intellectual Property Organization, WO2022083707 A1. 2022-04-28.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6209828-01 0.1 mL
WNK2 (Serine/threonine-protein Kinase WNK2, Protein Kinase With No Lysine 2, Protein Kinase Lysine-deficient 2, Serologically Defined Colon Cancer Antigen 43, Antigen NY-CO-43, KIAA1760, PRKWNK2, SDCCAG43) (Azide Free) (MaxLight 550)
Ask
View Details MBS6209828-02 5x 0.1 mL
WNK2 (Serine/threonine-protein Kinase WNK2, Protein Kinase With No Lysine 2, Protein Kinase Lysine-deficient 2, Serologically Defined Colon Cancer Antigen 43, Antigen NY-CO-43, KIAA1760, PRKWNK2, SDCCAG43) (Azide Free) (MaxLight 550)
Ask
View Details